Safety and efficacy of combination olaparib (O) and temozolomide (T) in small cell lung cancer (SCLC).

8571Background: SCLC is a high-grade neuroendocrine malignancy with overall response rates (ORR) to second-line chemotherapy generally ranging from 10-30%. The poly(ADP-ribose) polymerase (PARP) in...